NanoVibronix, Inc. (NAOV) shares surged 71.80 percent to $11.15 on Monday, rising $4.66, after the company announced that its subsidiary ENvue Medical Holdings LLC was issued U.S. Patent No. 12,409,105 B2, covering its "Insertion Device Positioning Guidance System and Method." The patent strengthens NanoVibronix's portfolio in non-invasive therapeutic systems. The stock opened at $9.43 and traded between $8.86 and $17.40, compared with a prior close of $6.49 on the Nasdaq. Trading volume spiked to 51.6 mil ...